Plastic particles are entering our bodies through everyday activities. Researchers have detected these particles in human blood, placentas, and lung tissue, demonstrating that environmental exposure leads to internal presence.
The challenge with understanding plastic exposure goes beyond just finding the particles. Analytical methods for detecting nano-sized plastics are still evolving, contamination control during testing remains difficult, and there's substantial uncertainty in measuring how much plastic actually enters and persists in the body.
The Two Main Routes: Ingestion and Inhalation
Based on current evidence, the primary ways microplastics and nanoplastics enter the body are through ingestion and inhalation. These aren't occasional exposures but continuous, daily pathways that most people encounter without realizing it.
Ingestion: Food, Water, and Indoor Dust
You're likely swallowing plastic particles with every meal and glass of water. Microplastics have been found in both tap and bottled water, with some evidence pointing to higher particle counts in water packaged in plastic bottles.
A 2024 study using advanced detection methods found approximately 240,000 plastic particles per liter in several popular bottled water brands, with about 90% classified as nanoplastics under 1 micrometer in size. However, the researchers could only identify about 10% of the particles they detected, meaning the total could be even higher than reported.
Food is another major source. Reviews have consistently reported microplastics in seafood, shellfish, salt, and other products, though comprehensive measurements across all foods remain incomplete. Food packaging and processing equipment can contribute additional particles to what you eat.
Even the dust in your home plays a role. You unintentionally swallow indoor dust through hand-to-mouth transfer and when airborne particles settle onto food.
For infants, the situation may be more intense. Polypropylene baby bottles can release extremely high particle counts when prepared with hot water. One study found up to 16.2 million particles per liter under typical bottle-warming conditions, making formula preparation a significant ingestion pathway for babies.
Why Ingestion Can Lead to Internal Presence
Most larger microplastic particles are expected to pass through the digestive system and be excreted. The UK Committee on Toxicity notes that over 90% of microplastics are likely eliminated this way. However, smaller particles present a different situation.
Particles smaller than 20 micrometers have been reported to cross biological membranes, though much of this evidence comes from animal and laboratory studies rather than direct human data. The World Health Organization notes that particles larger than 150 micrometers are unlikely to be absorbed and should be excreted, while absorption of very small microplastics and nanoplastics may be higher.
The detection of plastic polymers in human blood (particles 700 nanometers and larger) in a 2022 study of 22 donors demonstrates that some particles do enter the bloodstream. About 77% of the blood samples contained detectable plastic particles, with an average concentration of 1.6 micrograms per milliliter.
Inhalation: The Air You Breathe Indoors and Out
Airborne microplastic fibers and fragments are present in both outdoor and indoor air. Multiple research reviews conclude that indoor environments may be major contributors to overall exposure, with textiles, carpets, furniture, and household activities releasing particles you can inhale or that later settle onto food.
Workplace exposure can be significantly higher for people in certain occupations, such as synthetic textile production, plastic manufacturing, or recycling facilities. Some reports have linked high dust exposure in these settings to respiratory symptoms, though the evidence base remains limited.
Why Inhalation Can Lead to Internal Presence
While the airways have clearing mechanisms like mucociliary transport and macrophages that can remove deposited particles, some may persist. This depends on particle size, shape (especially fibers), and individual lung physiology.
Direct evidence comes from autopsy studies. In one 2021 study of 20 individuals, researchers found microplastics in lung tissue from 13 samples. All polymeric particles detected were smaller than 5.5 micrometers, and fibers ranged from 8.12 to 16.8 micrometers. The most frequently found polymers were polyethylene and polypropylene.
Nanoplastics, being smaller, can potentially reach deeper lung regions and may have a higher chance of moving beyond the lungs into other tissues, though human data on this translocation remains limited.
What About Skin Contact?
Dermal exposure occurs through direct contact with plastic particles in personal care products (historically including microbeads), workplace dust, and contaminated water. However, current research suggests this pathway is less concerning than ingestion and inhalation.
A comprehensive 2025 review concludes that skin acts as a highly effective barrier. Most studies show particles remain in the outer skin layers and hair follicles, with limited evidence of penetration into deeper tissues. Another broad review of nano- and microplastics concluded that dermal translocation is rather unlikely compared with digestive and respiratory routes.
This doesn't mean skin exposure is impossible, especially if skin integrity is compromised or in high-exposure occupational settings. But for most people in everyday situations, it's probably not the main driver of internal accumulation.
Other Routes: Medical and Maternal-Fetal Transfer
Some exposure pathways can bypass the body's normal barriers entirely.
Medical exposure represents direct entry into the bloodstream for some patients. Microplastics have been measured in certain intravenous infusion solutions, meaning patients receiving frequent or high-volume infusions may be exposed through their medical care.
Perhaps most concerning is maternal-fetal transfer. Microplastics have been detected in human placentas. In one 2021 study, researchers found 12 microplastic fragments (ranging from 5 to 10 micrometers) in 4 out of 6 placentas examined. The particles were distributed among the fetal side, maternal side, and chorioamniotic membranes, indicating that plastic particles can reach the maternal-fetal interface.
This demonstrates systemic transport in pregnant individuals and raises questions about fetal exposure, though whether particles actually cross into the fetus remains uncertain from current human data.
The Importance of Size: Why Nanoplastics Matter More
Not all plastic particles pose the same level of concern for internal accumulation. Size appears to be the critical factor.
Larger microplastics (those you could potentially see with a microscope) are generally thought to pass through the body without crossing into tissues. But nanoplastics, which measure less than 1 micrometer, are small enough to potentially interact with cells directly and may more readily move into internal tissues.
The problem is that nanoplastics are extraordinarily difficult to measure. Many environmental and human biomonitoring studies have historically focused on larger microplastics because they're easier to detect. This means nano-sized particles are often missed entirely, and we may be dramatically underestimating actual exposure.
The 2024 bottled water study's findings illustrate this challenge. Using detection limits of 100 nanometers, researchers found 10 to 100 times more plastic particles than previous studies that couldn't detect such small sizes. Yet even with these advanced methods, particles below 100 nanometers wouldn't be counted.
What We Still Don't Know
Despite these findings, massive gaps remain in our understanding.
We don't have good data on how much plastic the average person actually absorbs versus what passes through their system. We don't know how long particles stay in the body or whether they're eventually cleared. We don't understand the specific mechanisms by which particles cross from the gut or lungs into blood and tissues in humans, as most mechanistic data comes from animal or cell studies.
Contamination control during research remains a major challenge. Plastic is everywhere in labs and equipment, making it difficult to distinguish environmental contamination from actual samples. This affects confidence in all biomonitoring results.
Particle properties matter tremendously. Size, shape, polymer type, and surface chemistry all likely influence exposure and effects, but exposure metrics aren't standardized. Some studies report particle counts, others report mass, making comparisons difficult.
Most critically, we don't yet know the health implications. The studies discussed here demonstrate that particles can and do enter the body, but establishing whether this internal presence causes harm, and at what levels, requires different types of research that are still underway.
What This Means for You
The research reveals that plastic particle exposure is not a future concern but a current reality. Through eating, drinking, and breathing during normal daily activities, most people are likely experiencing ongoing exposure to microplastics and nanoplastics.
The detection of particles in blood, lung tissue, and placenta confirms that some of this environmental exposure results in measurable internal presence. Whether this represents brief passage through the body or actual long-term accumulation remains uncertain.
For those concerned about reducing exposure, the evidence points most strongly to ingestion and inhalation as the primary pathways. However, plastic particles are so widespread in food, water, and air that complete avoidance appears unrealistic with current technology and infrastructure.
What's needed now is better measurement of actual human exposure levels, clearer understanding of particle behavior in the body, and research into whether current exposure levels pose health risks. Until that science develops, we're operating with confirmed exposure but substantial uncertainty about its ultimate significance.
Frequently Asked Questions
How much plastic are we actually ingesting and inhaling daily?
Precise daily intake estimates remain uncertain due to measurement challenges and variability across different foods, water sources, and indoor environments. The 2024 bottled water study detected approximately 240,000 particles per liter in some brands, but daily total intake depends on consumption patterns, food choices, and air quality. Contamination control issues and evolving analytical methods mean current estimates have substantial uncertainty.
Are smaller nanoplastic particles more dangerous than larger microplastics?
The research suggests that smaller particles have a higher likelihood of crossing biological barriers in the gut and lungs to reach internal tissues, based on particle size and the body's filtration mechanisms. The WHO notes that particles larger than 150 micrometers are unlikely to be absorbed, while smaller microplastics and especially nanoplastics may have higher absorption potential. However, whether this translocation results in actual harm is not yet established by the current evidence.
What polymer types have been detected in human tissues?
The blood study detected polyethylene terephthalate (PET), polyethylene, and polymers of styrene most frequently, followed by poly(methyl methacrylate). The lung tissue study most frequently found polyethylene and polypropylene. The placenta study identified polypropylene in some fragments. These represent common, high-production-volume plastics used in bottles, packaging, textiles, and consumer products.
Do most microplastics get eliminated from the body, or do they accumulate?
According to the UK Committee on Toxicity, the majority of microplastics (more than 90%) are expected to be excreted through normal digestive processes. However, small amounts may remain in the gastrointestinal tract or potentially move into organs, particularly for very small microplastics and nanoplastics. The research currently cannot definitively distinguish between temporary presence during passage through the body versus long-term tissue accumulation, as human toxicokinetic data (absorption rates, clearance pathways, half-life) are still limited.
How do microplastics cross from the gut into the bloodstream?
The UK Committee on Toxicity notes that particles may cross the intestinal barrier through endocytosis by specialized M cells or through paracellular persorption (passage between cells). A review states that microplastics less than 20 micrometers have been reported to cross biological membranes. However, the report acknowledges that these mechanisms are largely inferred from animal and laboratory studies, and human toxicokinetic data remain limited. The exact mechanisms in humans are not clearly understood.
Are plastic bottles the main source of microplastics in drinking water?
The WHO notes that plastic bottles and caps can be a source of particles in bottled water, and some evidence points to higher particle counts in water packaged in plastic versus tap water. The 2024 study found polyethylene terephthalate (PET), which is used to make many water bottles, as one of the most common particle types detected. However, water can also contain microplastics from environmental sources before bottling, and tap water contains microplastics as well, so bottles are one contributor among multiple sources.
How reliable are these studies given the contamination challenges?
The report explicitly states that contamination control is a major challenge in microplastic research because plastics are ubiquitous in laboratory environments and equipment. This affects confidence in all biomonitoring results. The human tissue studies (blood, placenta, lung) did employ contamination control measures, but rigorous blanks and quality assurance/control protocols are critical for reliable results. The report emphasizes that this uncertainty means estimates of how much plastic enters and persists in the body have "substantial uncertainty."
Were the human tissue studies done on healthy people or people with health conditions?
The blood study involved 22 healthy volunteers from the general public. The placenta study involved 6 women with physiological (normal, healthy) pregnancies who met specific exclusion criteria to rule out various health conditions, medications, and behaviors that could confound results. The lung study involved autopsy samples from 20 individuals (median age 78.5 years). The studies were not designed to determine health effects but rather to establish whether particles are present in human tissues under real-world exposure conditions.
How many particles were found in the blood and placenta samples?
The blood study detected plastic particles in 77% of the 22 samples tested (17 out of 22), with a mean concentration of 1.6 micrograms per milliliter. The study detected particles 700 nanometers and larger. The placenta study found 12 microplastic fragments (ranging from 5 to 10 micrometers in size) across 4 out of 6 placentas examined, distributed among fetal side, maternal side, and chorioamniotic membranes. The particles were all pigmented, with 3 identified as polypropylene.
Do we know if fetuses are exposed to microplastics through the placenta?
The placenta study detected microplastics at the maternal-fetal interface, indicating that particles can reach this boundary. This demonstrates systemic transport in pregnant individuals. However, the report states that "whether particles (at least in the micro-size range measured) can reach the maternal-fetal interface" is what the evidence shows, implying presence at the interface. The report does not state that particles definitively cross into fetal tissue itself based on current human evidence, only that they reach the placenta.
Note: This article is based on a January 2026 evidence synthesis reviewing peer-reviewed studies and authoritative agency reports on microplastic and nanoplastic exposure routes. It focuses on exposure pathways and internal detection, not health outcomes or risk assessment.
References
- Kannan K, Vimalkumar K. A Review of Human Exposure to Microplastics and Insights Into Microplastics as Obesogens. Frontiers in Endocrinology. 2021;12:724989.
- Ramsperger AFRM, et al. Nano- and microplastics: a comprehensive review on their exposure routes, translocation, and fate in humans. NanoImpact. 2023;29:100441.
- Zuri G, Karanasiou A, Lacorte S. Microplastics: Human exposure assessment through air, water, and food. Environment International. 2023;179:108150.
- World Health Organization (WHO). Microplastics in drinking-water: Key questions and answers. 2019.
- National Institutes of Health (NIH). Plastic particles in bottled water. NIH Research Matters. January 23, 2024. [Original study: Qian N, et al. Rapid single-particle chemical imaging of nanoplastics by SRS microscopy. PNAS. 2024;121(3):e2300582121.]
- Leslie HA, van Velzen MJM, Brandsma SH, et al. Discovery and quantification of plastic particle pollution in human blood. Environment International. 2022;163:107199.
- Ragusa A, Svelato A, Santacroce C, et al. Plasticenta: First evidence of microplastics in human placenta. Environment International. 2021;146:106274.
- Amato-Lourenço LF, Carvalho-Oliveira R, Ribeiro Júnior G, et al. Presence of airborne microplastics in human lung tissue. Journal of Hazardous Materials. 2021;416:126124.
- UK Committee on Toxicity (COT). Microplastic Inhalation Statement (COT Statement 2024/01). January 2024.
- McLean P, Christopher EA, Sleeuwenhoek A, et al. Dermal exposure, review of current knowledge on the uptake of micro-and nano-plastics. Microplastics and Nanoplastics. 2025.
- Ramos Guerrero L, et al. Health Risks from Microplastics in Intravenous Infusions: Evidence from Italy, Spain, and Ecuador. 2025. PubMed Central: PMC12298248.
- Li D, Shi Y, Yang L, et al. Microplastic release from the degradation of polypropylene feeding bottles during infant formula preparation. Nature Food. 2020;1:746-754.
0 comments